{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:08:08Z","timestamp":1792670888678,"version":"4.5.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","award":["Not known"],"award-info":[{"award-number":["Not known"]}],"id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.1080\/21645515.2020.1733869","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T18:57:47Z","timestamp":1585767467000},"page":"1306-1312","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study"],"prefix":"10.1080","volume":"16","author":[{"given":"Timo","family":"Vesikari","sequence":"first","affiliation":[{"name":"Vaccine Research Center, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, Public Health England, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino","family":"Forsten","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, University of Tampere, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Findlow","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, Public Health England, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-7165","authenticated-orcid":false,"given":"Mandeep S.","family":"Dhingra","sequence":"additional","affiliation":[{"name":"Global Clinical Sciences, Sanofi Pasteur, Swiftwater, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Jordanov","sequence":"additional","affiliation":[{"name":"Global Clinical Sciences, Sanofi Pasteur, Swiftwater, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1258308"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S28410"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0147"},{"key":"cit0008","unstructured":"Control ECfDPa. Disease data from ECDC Surveillance Atlas for meningococcal disease. Solna (Sweden): European Centre for Disease Prevention and Control; 2017."},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30157-3"},{"key":"cit0010","unstructured":"World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Weekly epidemiological record: No.47. 2001;86:521\u201340."},{"key":"cit0011","unstructured":"Sanofi Pasteur Inc. 284 Menactra\u00ae Highlights of prescribing information. Lyon (France): Menactra\u00ae (package insert); 2018."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0196-z"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.056"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.07.026"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"cit0016","first-page":"1","author":"Findlow J","year":"2019","journal-title":"Hum Vaccine Immunother"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318268dfe4"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.4.2.156-167.1997"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00068-09"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.019"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.060"},{"key":"cit0022","unstructured":"Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 2005;54:1\u201321."},{"key":"cit0023","unstructured":"European Medicines Agency. Assessment report for Menveo. Amsterdam, The Netherlands: EMA; 2010."},{"key":"cit0024","unstructured":"European Medicines Agency. Assessment report: Nimenrix. Amsterdam, The Netherlands: EMA; 2012."},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ512"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.2165\/11204790-000000000-00000"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4946-4954.2002"},{"key":"cit0028","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. Stockholm (Sweden): ECDC. Annual Epidemiological Report for 2015; 2017."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1733869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T20:46:27Z","timestamp":1629233187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1733869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["10.1080\/21645515.2020.1733869"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1733869","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}